Priced like the old business, running like a new one: management is redirecting the call away from the metric investors
The model's full reasoning — Q3 2021 call → NOWe need to determine if management repeatedly redirects attention away from the conventional measure and toward a different part of the business that is already earning, and indicates that the record hasn't caught up. The conventional yardstick for LeMaitre is likely overall sales growth, operating income, EPS, etc. Management discusses Q3 sales, growth, guidance, etc. But do they set aside the conventional yardstick? They talk about sales growth, but they also talk about sales force expansion, Artegraft, etc. However, the question is about redirecting attention away from the measure by which the company is conventionally judged. The conventional measure might be overall revenue growth or earnings. Management does not seem to set that aside. They discuss sales, margins, operating income, guidance. They also discuss sales force expansion and Artegraft performance. But do they say that the conventional yardstick is no longer the right thing to watch? No. They are still guiding on sales and operating income. They are not saying "ignore the headline number, look at this other thing." They are just discussing various aspects. The phenomenon described is like a company saying "the market focuses on our commodity price, but actually our real earnings come from our services business which is already earning, and the reported numbers don't reflect that yet." Here, management is not doing that. They are discussing sales growth, but they also discuss Artegraft as a key driver. But they don't set aside the overall sales figure. They are still presenting it as the main metric. They also discuss sales force expansion as a future driver, but that's not already earning. They mention Artegraft is already earning, but they don't say that the conventional yardstick (overall sales) is not the right one. They are just providing detail. Thus, the answer is NO. Let's double-check: Is there any point where management says "don't look at this, look at that"? No. They are just answering questions. They discuss Artegraft as a strong performer, but they don't say that the overall sales figure is misleading. They also discuss sales force expansion as a future investment. So no redirection. Therefore, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NOAH | Noah Holdings Limited | Q1 2024 | 2024-05-30 | D |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CALX | Calix, Inc. | Q1 2023 | 2023-04-20 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| LOB | Live Oak Bancshares, Inc. | Q3 2018 | 2018-10-25 | C+ |
SPT · Q2 2023 → YESThe question is whether management repeatedly redirects attention away from the conventional measure toward a different part of the business that's already earning today, and indicates that this diffe...YES The transcript shows management repeatedly reframing away from the conventional total ARR/revenue growth metric (which is being distorted by unpredictable low-end non-core ARR) toward the higher-quality up-market/enterprise segment that is already delivering record new business ACVs, 50%+ YoY growth, and 43% of 2023 ARR. They explicitly set the low-end aside by removing it from forecasts and modeling to give “greatest visibility,” note that Q2 ARR growth will be the lowest pace of the year because of this change, and indicate the reported figures still reflect the old mix while the new up-market story is already earning today (with Tagger adding further upside not yet reflected). This creates the coherent posture of redirecting attention from the headline growth number outsiders watch to the part of the business that is already producing real results.
WD · Q2 2022 → YESThe question is about whether management repeatedly redirects attention away from the conventional measure to a different part of the business that's already earning today, and indicates that this isn...YES The transcript shows management repeatedly reframing the discussion away from the conventional multifamily agency lender yardstick (origination volumes, GSE lending, MSR-driven EPS) toward the diversified services and asset-management businesses that are already generating substantial cash revenue and EBITDA today. They explicitly set the old metric aside by introducing adjusted EPS to “strip out non-cash mortgage servicing rights,” highlight the shift from “lending-centric” to “broader technology-enabled financial services,” and note that segment results now provide “more transparency into our operating structure.” They point to debt brokerage, property sales, SAM (Alliant, Zelman), small-balance lending, and appraisals as the new earning engines, describing their concrete contributions (e.g.
CALX · Q1 2023 → YESThe question is about whether management repeatedly redirects attention away from the conventional measure to a different part of the business that's already earning today, and indicates that this isn...YES The transcript shows management repeatedly framing the company as operating in a "new market" centered on platforms, clouds, and managed services—distinct from the legacy hardware/cyclical model—while highlighting real earnings from these areas (e.g., 988 BSPs deploying platforms, 865 cloud customers, 334 with 41 new managed services in Q1, record Intelligent Access EDGE revenue). They indicate this is already producing revenue and customer adoption but remains early-stage ("this is the beginning," "early stage of where we are in this new market"), with reported results still reflecting the prior hardware-focused picture.